Literature DB >> 9222977

A report of a child with a deletion (9)(q34.3): a recognisable phenotype?

H Ayyash1, R Mueller, E Maltby, P Horsfield, N Telford, R Tyler.   

Abstract

We report a case of a male infant who presented with congenital anomalies and was found to have a de novo deletion in the terminal region of the long arm of chromosome 9. He died at the age of 17 weeks of cardiorespiratory failure owing to RSV positive bronchiolitis. A review of previously published reports documented one previous report of a patient with a deletion of (9)(q34.3) and multiple congenital anomalies. Comparison with the previously reported case suggests that the phenotype observed constitutes a clinically recognisable pattern of malformations.

Entities:  

Mesh:

Year:  1997        PMID: 9222977      PMCID: PMC1051009          DOI: 10.1136/jmg.34.7.610

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  3 in total

1.  [Intercalary deletions of 9q].

Authors:  C Turleau; J de Grouchy; J P Chabrolle
Journal:  Ann Genet       Date:  1978-12

Review 2.  Patients with deletions of 9q22q34 do not define a syndrome: three case reports and a literature review.

Authors:  S A Farrell; J Siegel-Bartelt; I Teshima
Journal:  Clin Genet       Date:  1991-09       Impact factor: 4.438

3.  Infant with multiple congenital anomalies and deletion (9)(q34.3).

Authors:  L A Schimmenti; S A Berry; M Tuchman; B Hirsch
Journal:  Am J Med Genet       Date:  1994-06-01
  3 in total
  2 in total

1.  Pulmonary hypertension in patients with 9q34.3 microdeletion-associated Kleefstra syndrome.

Authors:  Volkan Okur; Shannon Nees; Wendy K Chung; Usha Krishnan
Journal:  Am J Med Genet A       Date:  2018-07-31       Impact factor: 2.802

2.  Update on Kleefstra Syndrome.

Authors:  M H Willemsen; A T Vulto-van Silfhout; W M Nillesen; W M Wissink-Lindhout; H van Bokhoven; N Philip; E M Berry-Kravis; U Kini; C M A van Ravenswaaij-Arts; B Delle Chiaie; A M M Innes; G Houge; T Kosonen; K Cremer; M Fannemel; A Stray-Pedersen; W Reardon; J Ignatius; K Lachlan; C Mircher; P T J M Helderman van den Enden; M Mastebroek; P E Cohn-Hokke; H G Yntema; S Drunat; T Kleefstra
Journal:  Mol Syndromol       Date:  2012-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.